Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples